TherapyEdge, Right to Care Launch The TherapyEdge
TherapyEdge and Right to Care have developed a model of care for antiretroviral therapy treated patients, from treatment initiation sites to primary health care centers. Right to Care
TherapyEdge and Right to Care have developed a model of care for antiretroviral therapy treated patients, from treatment initiation sites to primary health care centers. Right to Care
Kofax, a provider of Intelligent Capture and Exchange solutions, has signed a $350,000 contract with EDCO Group. EDCO would utilize Kofax software to automate the processing of millions
NXP has announced collaboration with Siemens on an RFID-based supply chain pharmaceutical project designed to improve efficiency from manufacture to retail. Using NXP’s Application and System Center (ASC,
Metropolitan Health Networks (Metcare) has selected eClinicalWorks unified electronic medical records (EMR) and practice management solution for its nine internal medicine offices in South and Central Florida. The
CareMedic, a provider of solution for managing patient financial data, has entered into an OEM agreement with Cincom Systems. The deal is for its Cincom Knowledge Master software,
Emdeon has acquired eRx Network (eRx). The transaction combines Emdeon’s existing pharmacy operations with eRx’s customer base, product innovation, customer support and pharmacy switching technology. In connection with
Omega Medical has selected Allscripts’ Practice Management and Payerpath claims management solution, for its physician practice clients across South Carolina and the surrounding states. Omega would deliver both
Virginia Mason has chosen Carefx’ Fusionfx Solution Suite to deliver interoperability between its multiple information systems. The company claims that Fusionfx Solution Suite synchronizes patient data across existing
Allscripts has announced that Diagnostic Center of Medicine (DCOM) has selected Allscripts Electronic Health Record (EHR) and Practice Management (PM) for its physicians in three locations. DCOM is
GlaxoSmithKline (GSK) has received a complete response letter from FDA, related to the application for casopitant (Rezonic). The company is reviewing it and will slot in with the